We appreciate Dr. Morais‐Almeida's comments 1 about our Letter to the Editor, presenting additional literature about asthma prevalence in severe COVID‐19‐infected patients and highlighting data that contrast our hypothesis that asthma, particularly type 2 asthma, may be protective against severe disease.
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification. Reply to Morais-Almeida / Carli G.; Cecchi L.; Stebbing J.; Parronchi P.; Farsi A.. - In: ALLERGY. - ISSN 0105-4538. - STAMPA. - 76:(2020), pp. 955-956. [10.1111/all.14537]
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification. Reply to Morais-Almeida
Parronchi P.;
2020
Abstract
We appreciate Dr. Morais‐Almeida's comments 1 about our Letter to the Editor, presenting additional literature about asthma prevalence in severe COVID‐19‐infected patients and highlighting data that contrast our hypothesis that asthma, particularly type 2 asthma, may be protective against severe disease.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
